Surgery: Total hip replacement Surgery
Conditions
Interventions
Randomised controlled trial - 128 patients undergoing primary total hip replacement will be randomised at time of surgery. They will undergo the gold standard Exeter hip replacement in the usual fashi
Sponsors
Department of Health
Eligibility
Inclusion criteria
Inclusion criteria: Any patient undergoing routine primary total hip replacement will be eligible. They will be approached at pre-assessment clinic and offered the opportunity to be involved in the research. Informed written consent to partake will be mandatory for inclusion and any patient who declines will be excluded. If they are happy to consent at this stage, consent will be given. If they require an opportunity to discuss the study with their family or GP, they may do so, and at time of admission to hospital for surgery will sign the consent form if they are happy to be included. Adult subjects only - of any age.
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to provide an evidence base regarding the most appropriate wound size in primary hip replacement. If significant benefit is found in one arm of the trial compared to the other, this practise will be adopted across the HIP Unit in primary THR. Thus, the research question that is being asked is: Does a small incision confer any greater benefit to patients when compared to use of a standard incision in primary total hip replacement? We plan to perform a randomised, controlled prospective trial to answer this question. Study endpoints: Comparison of peri-operative blood loss, post-operative haemoglobin levels and need for transfusion, length of hospital stay, comparison of operated limb swelling, pain measurement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed